Pharmafile Logo
Pharmafocus logo
Advanced Search
nurofen

Nurofen maker hit by $6m fine over “misleading conduct”

December 16, 2016
Sales and Marketing Nurofen, Reckitt Benckiser

After a case last year levied by the Australian Federal Court over “misleading conduct” concerning the marketing of its branded …

News
1511671_logo_1456919640

MSD-Gilead patent squabble ends in $2.54 billion verdict

December 16, 2016
Medical Communications

A patent lawsuit between Gilead Sciences and MSD, known as Merck in the US, has resulted in MSD being awarded …

News
top_ten_1

Top Ten most popular articles on Pharmafile.com this week

December 16, 2016
Medical Communications biggest news, biggest stories, top 10, top 10 stories, top stories, top ten

Christmas is nearly here, but there isn’t much Christmas cheer to be had in the pharmaceutical industry. It’s been a …

News
dominos

Six generics companies hit by 20-state-strong lawsuit

December 16, 2016
Medical Communications Heritage, Mylan, Teva

Following hot on the heels of yesterday’s news that a former CEO and president of Heritage Pharmaceuticals had been charged …

News

Actavis UK overcharged NHS with 12,000% price hike, watchdog says

December 16, 2016
Medical Communications, Sales and Marketing Actavis, CMA, NHS

Actavis UK has been accused by the Competition and Markets Authority (CMA) of overcharging the NHS by selling its hydrocortisone …

News

Insider interview: NICE discusses its planned ‘fast-track’ appraisal process

December 16, 2016
Medical Communications, Sales and Marketing NICE

Jenniffer Prescott, associate director of planning, operations and topic selection, answers questions on NICE’s recent plans for a ‘fast-track’ appraisal …

News
bart_de_strooper_cropped

Bart de Strooper chosen as new director of UK Dementia Research Institute

December 15, 2016

Bart de Strooper has been chosen as the new director of the UK Dementia Research Institute (UK DRI), and University …

Appointment
shutterstock_311949818

First human trial of tau-targeting Alzheimer’s vaccine shows promise

December 15, 2016
Medical Communications, Research and Development Alzheimer's

The latest in a succession of promising announcements surrounding Alzheimer’s R&D, researchers at the Karolinska Institutet in Stockholm, Sweden have …

News
gsk_wall

GSK opens state-of-the-art global vaccine centre

December 15, 2016
Manufacturing and Production, Medical Communications

GlaxoSmithKline has opened its new global vaccines R&D centre in Rockville, Maryland, to add to its two existing facilities in …

News

Pfizer’s next blockbuster given FDA approval

December 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, atopic dermatitis, eczema

Pfizer announced that it had received approval for its eczema treatment, Eucrisa, for patients of two years of age and …

News
lonza

Lonza in $5.5 billion deal to acquire Capsugel

December 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Capsugel, Lonza, acquistion

Lonza, the Basel-based supplier to the pharmaceutical, biotech and nutrition industry, has announced that it will acquire Capsugel for $5.5 …

News
digital_pharma

NICE and FDA to collaborate in medtech access scheme

December 15, 2016
Medical Communications, Sales and Marketing FDA, NICE

The National Institute of Health and Care Excellence (NICE) and the US Food and Drugs Administration (FDA) have announced their …

News
justice_department

Former CEO and president of generics company charged with price fixing

December 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jeffrey glazer, heritage pharmaceuticals, jason malek

Jeffrey Glazer, ex-CEO of Heritage Pharmaceuticals, and Jason Malek, the former president, have been charged with conspiracy to fix prices. …

News
shutterstock_92671375

Five major pharma firms break ABPI code of conduct, according to watchdog

December 15, 2016
Medical Communications, Sales and Marketing ABPI, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Grunenthal, Janssen

Eli Lilly, Boehgringer Ingelheim, AstraZeneca UK, Grunenthal and Janssen-Cilag have been “named and shamed” by the Prescription Medicines Code of …

News
dementia

Director and location of £250 million UK Dementia Research Institute revealed

December 14, 2016
Medical Communications, Research and Development Alzheimer’s Research UK, Medical Research Council, alzheimer's research uk, alzheimer's society

Bart de Strooper has been chosen as the new director of the UK Dementia Research Institute (UK DRI), and University …

News
ritalin-sr-20mg-1000x1000

35% of all imported medicine in Guyana is fake, investigation finds

December 14, 2016
Medical Communications, Research and Development, Sales and Marketing Guyana, counterfeit medicine

As much as 35% of medicine imported into Guyana is fake and unsafe for use, according to findings by Allan …

News
new_york

New York in $500 million de Blasio-backed biotech boost

December 14, 2016
Manufacturing and Production, Research and Development New York, biotech, funding

Mayor of New York, Bill de Blasio, has announced a $500 million initiative to drive the development of the biotech …

News
actelion

Sanofi eyes Actelion merger as J&J backs down

December 14, 2016
Medical Communications, Research and Development, Sales and Marketing Actelion, Johnson & Johnson, Sanofi

After days of negotiations, Johnson and Johnson has stepped down from its attempts to acquire Swiss blood-pressure specialist Actelion, while …

News
barack-obama-1174489_960_720

Obama seals $6.3 billion 21st Century Cures Act

December 14, 2016
Medical Communications, Research and Development Biden, Obama, US, congress

President Barack Obama put pen to paper on the 21st Century Cures Act on 13 December, which commits to investing …

News

Lilly offers insulin at 40% discount

December 13, 2016
Research and Development, Sales and Marketing Blink Health, Eli Lilly

Eli Lilly has announced that it will offer its insulin medication, including Humalog, at a 40% discount for eligible patients …

News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026